Arti Parwani

Alternate molecular genetic pathways in ovarian carcinomas of common histological typesWillner J, Wurz K, Allison KH, et al (Univ of Washington, Seattle) Hum Pathol 38:607–613, 2007§

Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?Tong G-X, Chiriboga L, Hamele-Bena D, et al (Columbia Univ, New York; New York Univ) Mod Pathol 20:856–863, 2007§

Ovarian Nonsmall Cell Neuroendocrine Carcinoma: A Clinicopathologic and Immunohistochemical Study of 11 CasesVeras E, Deavers MT, Silva EG, et al (Univ of Texas at Houston) Am J Surg Pathol 31:774–782, 2007§

HMB-45 Reactivity in Conventional Uterine LeiomyosarcomasSimpson KW, Albores-Saavedra J (Louisiana State Univ, Shreveport) Am J Surg Pathol 31:95–98, 2007§

Utility of Immunohistochemistry in Predicting Microsatellite Instability in Endometrial CarcinomaModica I, Soslow RA, Black D, et al (Mem Sloan-Kettering Cancer Ctr) Am J Surg Pathol 31:744–751, 2007§

Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkersBalmer NN, Richer JK, Spoelstra NS, et al (Univ of Colorado, Denver; Penrose Hosp, Colorado Springs) Mod Pathol 19:1593–1605, 2006§

Clinicopathologic Features of Rhabdomyosarcoma of Gynecologic Origin in AdultsFerguson SE, Gerald W, Barakat RR, et al (Mem Sloan-Kettering Cancer Ctr) Am J Surg Pathol 31:382–389, 2007§

The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significanceNam EJ, Kim JW, Kim SW, et al (Women's Cancer Clinic, Korea; Yonsei Univ, Seoul, Korea) Gynecol Oncol 104:207–211, 2007§

Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implantsSieben NL, Roemen GMJM, Oosting J, et al (Univ of Maastrict, The Netherlands; Leiden Univ, The Netherlands; Autonomous Univ of Barcelona) J Pathol 210:405–411, 2006§

Human Kidney Injury Molecule-1 (hKIM-1): A Useful Immunohistochemical Marker for Diagnosing Renal Cell Carcinoma and Ovarian Clear Cell CarcinomaLin F, Zhang PL, Yang XJ, et al (Geisinger Med Ctr, Danville, Pa; Northwestern Univ, Chicago; Fudan Univ, Shanghai, PR of China; et al) Am J Surg Pathol 31:371–381, 2007§